Modern science for better quality control of medicinal products "Towards global harmonization of 3Rs in biologicals": The report of an EPAA workshop.
暂无分享,去创建一个
Martin Bopst | Marlies Halder | Iwona Wilk-Zasadna | Katrin Schutte | Catrina Stirling | Ursula G Sauer | Paul Stickings | Robert H Levis | Sylvie Uhlrich | Klaus Cussler | K. Cussler | P. Stickings | U. Sauer | A. Szczepanska | M. Halder | Anna Szczepanska | David John | Joerg Garbe | Harrie L Glansbeek | Robin Levis | Pieter-Jan Serreyn | Dean Smith | Joerg H O Garbe | M. Bopst | H. Glansbeek | C. Stirling | Dean Smith | S. Uhlrich | I. Wilk-Zasadna | Katrin Schutte | David John | Pieter-Jan Serreyn | Martin Bopst
[1] W. Stokes,et al. Non-animal replacement methods for veterinary vaccine potency testing: state of the science and future directions , 2011, Procedia in Vaccinology.
[2] W. Stokes,et al. Alternative methods and strategies to reduce, refine, and replace animal use for veterinary vaccine post-licensing safety testing: state of the science and future directions , 2011 .
[3] W. Casey,et al. Non-animal replacement methods for human vaccine potency testing: state of the science and future directions , 2011, Procedia in Vaccinology.
[4] R. Tierney,et al. Development and use of a novel in vitro assay for testing of diphtheria toxoid in combination vaccines. , 2009, Journal of immunological methods.
[5] W. Russell,et al. Ethical and Scientific Considerations Regarding Animal Testing and Research , 2011, PloS one.
[6] Martin Bopst,et al. Historical Data Analyses and Scientific Knowledge Suggest Complete Removal of the Abnormal Toxicity Test as a Quality Control Test , 2014, Journal of pharmaceutical sciences.
[7] Alessandro Sette,et al. Reverse vaccinology: developing vaccines in the era of genomics. , 2010, Immunity.
[8] K. Cussler,et al. Quality control of inactivated erysipelas vaccines: results of an international collaborative study to establish a new regulatory test. , 2001, Vaccine.
[9] Marlies Halder,et al. The consistency approach for quality control of vaccines - a strategy to improve quality control and implement 3Rs. , 2011, Biologicals : journal of the International Association of Biological Standardization.
[10] M Schwanig,et al. Elimination of abnormal toxicity test for sera and certain vaccines in the European Pharmacopoeia. , 1997, Vaccine.
[11] R. Tierney,et al. In vitro antigen ELISA for quality control of tetanus vaccines. , 2012, Biologicals : journal of the International Association of Biological Standardization.
[12] Jianxun Xie,et al. Potential confounding effects of benzyl alcohol as a formulation excipient support the elimination of the abnormal toxicity test from pharmacopoeias. , 2015, Regulatory toxicology and pharmacology : RTP.